Botanical species · safety record

Bupleurum chinense

The EFSA Compendium of Botanicals holds 2 constituent measurements for Bupleurum chinense. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Bupleurum chinense DC.

2Constituent measurements
0Safety records
2Cited sources
1,143Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1,143 licensed products naming Bupleurum chinense as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA
  • Fresh
  • decoction
  • solid

Source material stated

  • Bupleurum Root extract
  • Bupleurum chinense root
  • Bupleurum scorzonerifolium - Root
  • Dried root(s)
  • New material
  • Radix
  • Rhizome
  • Root

What the records describe

Constituents measured

  • Carvone1
  • Saponins1

Plant parts

  • Roots and other underground parts2

Preparations

  • Essential oil1
  • Solvent extraction1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
CarvoneRoots and other underground partsEssential oil10.3 PercentGC-MSResolve DOI
SaponinsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Zhao, C., Zeng, Y., Wan, M., Li, R., Liang, Y., Li, C., Zeng, Z., Chau, F.-T. Comparative analysis of essential oils from eight herbal medicines with pungent flavor and cool nature by GC-MS and chemometric resolution methods. Journal of separation science, 2009, vol. 32, no. 4, p. 660-670. DOI
  2. Li, Dan-Qi., Wu, Jie., Liu, Li-Yin., Wu, Ying-Ying., Li, Ling-Zhi., Huang, Xiao-Xiao., Liu, Qing-Bo., Yang, Jing-Yu., Song, Shao-Jiang., Wu, Chun-Fu. Cytotoxic triterpenoid glycosides (saikosaponins) from the roots of Bupleurum chinense . Bioorganic & medicinal chemistry letters, 2015, vol. 25, no. 18, p. 3887-3892. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue